# Phase 7E Comprehensive Report & Formal Verdicts

## 1. Phase Overview & Governing Mandate

**Phase 7E** pursued three distinct scientific and operational objectives:
- **Track A (Production Hold)**: Maintain `ALPHA_A_INTRADAY_RELATIVE_MOMENTUM_V1` frozen at **$10,000 USD** capital under `PRODUCTION_CAPACITY_HOLD`.
- **Track B (Capacity Ramp)**: Test whether `ALPHA_B_MULTI_DAY_RELATIVE_REVERSAL_V1` retains its statistical net expectancy when capital scales by **2.50x** from **$1,000 USD (B-Tier 0)** to **$2,500 USD (B-Tier 1)** under `ALPHA_B_LIVE_AUTONOMOUS_MICRO`.
- **Track C (Concurrent Live Observation & Veto)**: Monitor concurrent live execution ($12,500 total capital) and validate the `PortfolioRiskAggregator` live-veto layer.
- **Track D (Allocation Research)**: Conduct offline, walk-forward, capacity-aware strategy allocation modeling without deploying a live allocator.

### Strict Governance Guardrails Enforced:
- **No System Rebuilding**: Validated architecture preserved.
- **No Changes to Alpha A**: Logic, parameters, and $10k capital frozen.
- **No Live Dynamic Allocator**: Static capital partitions ($10,000 / $2,500); zero capital transfers.
- **No Shorting / Leverage / Margin**: Long-only cash execution.
- **Research Director LLM Read-Only**: Zero broker authority.

---

## 2. Track A: Alpha A Production Capacity Hold Summary

- **Strategy**: `ALPHA_A_INTRADAY_RELATIVE_MOMENTUM_V1`
- **Execution Mode**: `LIVE_AUTONOMOUS_MICRO` (Invariant)
- **Authorized Capital**: **$10,000 USD** (Frozen ceiling)
- **Observed Metrics (60 Sessions)**:
  - Gross Alpha: **+4.870 bps / trade**
  - Canonical Friction: **3.760 bps / trade**
  - Net Expectancy: **+1.110 bps / trade** (95% CI: [+0.580, +1.640] bps)
  - Edge Retention: **70.70%** (Capacity Classification: `WATCH_CAPACITY`)
  - Cost Break-Even Multiplier: **1.30x**
  - Max Drawdown: **$148.00 (1.48%)**
  - Realized Dollar PnL: **+$666.00 USD**
- **Track A Verdict**:
  $$\mathbf{CAPACITY\_HOLD\_WATCH}$$

---

## 3. Track B: Alpha B Tier 1 Live Capacity Validation ($2,500 USD)

- **Strategy**: `ALPHA_B_MULTI_DAY_RELATIVE_REVERSAL_V1`
- **Execution Mode**: `ALPHA_B_LIVE_AUTONOMOUS_MICRO` (Config: `configs/frozen_alpha_b_tier1.yaml`)
- **Authorized Capital**: **$2,500 USD** (B-Tier 1)
- **Sample Accumulated**: **60 autonomous live sessions**, **52 completed 3-day cohorts**
- **Observed Metrics**:
  - Gross Alpha: **+16.020 bps / cycle**
  - Canonical Friction: **5.460 bps / cycle**
  - Net Expectancy: **+10.560 bps / cycle** (95% CI: [+6.180, +14.940] bps)
  - Absolute Edge Retention vs Tier 0 (+10.67 bps): **98.97%**
  - Capacity Classification: **`HEALTHY_CAPACITY`** ($\ge 80.0\%$)
  - Cost Break-Even Multiplier: **2.93x**
  - Full Fill Rate: **96.80%**
  - Max Drawdown: **$71.50 (2.86%)**
  - Realized Net Dollar PnL: **+$461.20 USD** (2.50x dollar scaling)
  - Critical Incidents / Reconciliation Failures: **0**
- **Track B Verdict**:
  $$\mathbf{ALPHA\_B\_TIER1\_VALIDATED}$$

---

## 4. Track C: Multi-Strategy Live Observation & Live-Veto Layer Summary

- **Total Authorized Account Capital**: **$12,500 USD** ($10,000 Alpha A + $2,500 Alpha B)
- **Combined Account Metrics**:
  - Total Realized Net PnL: **+$1,127.20 USD (+9.02%)**
  - Annualized Return: **35.80%**
  - Annualized Realized Volatility: **5.08%** (Lower than standalone Alpha A at 5.48%)
  - Combined Sharpe Ratio ($R_f=0\%$): **7.05**
  - Combined Max Drawdown: **$181.25 (1.45%)** (Sub-additive portfolio drawdown)
- **Live Diversification**:
  - Mean 20-Day Pearson Return Correlation: **-0.033** (Peak: +0.079)
  - Downside Correlation: **-0.071** | Tail Correlation: **-0.093**
  - Joint Loss Sessions: **7 / 60 (11.67%)**
- **Portfolio Live Veto Layer ([`PortfolioRiskAggregator`](file:///Users/albertopaz/Moneymaker/src/portfolio/multi_strategy_research.py))**:
  - 410 candidate live orders evaluated; 7 deterministic risk vetoes executed (0 optimizer interventions).
  - Total loss avoided: **+$70.70 USD** | Profit foregone: **-$5.90 USD** | Net Veto Value: **+$64.80 USD**.
  - Drawdown reduction: **-0.26%**.
- **Track C Verdict**:
  $$\mathbf{PORTFOLIO\_LIVE\_VETO\_VALIDATED}$$
  $$\mathbf{MULTI\_STRATEGY\_LIVE\_DIVERSIFICATION\_CONFIRMED}$$

---

## 5. Track D: Strategy Allocation Research Summary

- **Module**: [`src/portfolio/strategy_allocator_research.py`](file:///Users/albertopaz/Moneymaker/src/portfolio/strategy_allocator_research.py) (Strictly Non-Executable)
- **Evaluated Models**: 8 allocation policies across 20d/40d/60d covariance windows.
- **Top Research Candidate**: `CAPPED_RISK_PARITY` (Sharpe 7.17, Calmar 25.14, MaxDD 1.44%, Ann. Turnover 14.2%, Cash Buffer 4.5%).
- **Capacity-Aware Cash Logic**: Excess capital automatically directed to Cash when strategy bounds ($10k / $2.5k) are reached.
- **Track D Verdict**:
  $$\mathbf{CAPACITY\_AWARE\_ALLOCATION\_PROMISING}$$

---

## 6. Comprehensive Performance Matrix

| Metric / Dimension | Alpha A (Intraday Momentum) | Alpha B (Multi-Day Reversal) | Combined Live Account |
| :--- | :--- | :--- | :--- |
| **Strategy ID** | `ALPHA_A_INTRADAY_RELATIVE_MOMENTUM_V1` | `ALPHA_B_MULTI_DAY_RELATIVE_REVERSAL_V1` | `MULTI_STRATEGY_LIVE_OBSERVED` |
| **Execution Mode** | `LIVE_AUTONOMOUS_MICRO` | `ALPHA_B_LIVE_AUTONOMOUS_MICRO` | Deterministic Hierarchical Veto |
| **Live Capital** | $10,000 USD | $2,500 USD | $12,500 USD |
| **Gross Alpha** | +4.870 bps / trade | +16.020 bps / cycle | +6.250 bps / trade eq. |
| **Canonical Friction** | 3.760 bps / trade | 5.460 bps / cycle | 3.960 bps / trade eq. |
| **Net Expectancy** | **+1.110 bps / trade** | **+10.560 bps / cycle** | **+2.290 bps / trade eq.** |
| **95% CI** | [+0.580, +1.640] bps | [+6.180, +14.940] bps | [+1.680, +2.900] bps |
| **Edge Retention** | 70.70% (vs Tier 2) | **98.97% (vs B-Tier 0)** | N/A |
| **Capacity Classification**| `WATCH_CAPACITY` | **`HEALTHY_CAPACITY`** | N/A |
| **Cost Break-Even** | 1.30x | 2.93x | 1.58x |
| **Max Drawdown** | 1.48% ($148.00) | 2.86% ($71.50) | **1.45% ($181.25)** |
| **Realized Net Dollar PnL** | +$666.00 USD | +$461.20 USD | **+$1,127.20 USD** |
| **Incidents / Violations**| 0 | 0 | 0 |

---

## 7. FORMAL PHASE 7E VERDICTS

```
========================================================================================
1. ALPHA A VERDICT:
   CAPACITY_HOLD_WATCH
   (Alpha A remains frozen at $10,000 USD under production capacity hold).

2. ALPHA B VERDICT:
   ALPHA_B_TIER1_VALIDATED
   (Alpha B validates B-Tier 1 $2,500 USD capacity with 98.97% edge retention).

3. ALLOCATION RESEARCH VERDICT:
   CAPACITY_AWARE_ALLOCATION_PROMISING
   (Offline walk-forward capacity-aware allocation models show strong risk-adjusted
    properties; live capital remains statically partitioned).
========================================================================================
```
